Rua shareholders green light Zalm deal

Staff reporters
Thu, 20 Jan 2022

Rua chief executive Rob Mitchell told shareholders at a special meeting yesterday Zalm had developed three cannabis oil products. (Image: supplied)
Rua chief executive Rob Mitchell told shareholders at a special meeting yesterday Zalm had developed three cannabis oil products. (Image: supplied)
Staff reporters
Thu, 20 Jan 2022
Rua Bioscience shareholders have signed off on the $10 million equity purchase of cannabis firm Zalm Therapeutics.The deal, announced Nov 30, will see the Gisborne based medicinal cannabis firm issue 24.42m new shares at 41 cents a share, payable in three instalments of $3.3m based on "hitting production and regulatory milestones."Shareholder approval was required as the issue exceeded Rua's 15% placement capacity under NZX listing rules.Those milestones include receiving German regulatory approvals for the sale of cannabidiol (CB...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets Market close
NZ shares slide on recession risk
Dan Brunskill | Tue, 17 May 2022

Central banks are expected to rapidly tighten policy, the risk of an energy crisis in Europe remains, and economic activity in China has been slowing.

Markets
BitPrime calls on crypto community for cash
Dan Brunskill | Tue, 17 May 2022

The crypto retailers plan to create a decentralised autonomous organisation to give supporters a say in how the business is run. 

Technology
Tracksuit a good fit for brand tracking
Ben Moore | Tue, 17 May 2022

Startup Tracksuit is simplifying brand tracking as digital marketing faces the death of online tracking.

Sponsored
Grow your business by taking time to plan

Getting business fundamentals right gives the best chance at beating the unplannable.

Partner content
More fuel storage needed now

Boosting fuel reserves could prevent social & economic disruption.